Literature DB >> 15450875

Evolution of treatment for metastatic spine disease.

Adam S Wu1, Daryl R Fourney.   

Abstract

The management of patients with metastatic disease of the spine should be highly individualized and depends on several factors, including the clinical presentation, duration of symptoms, tu-mor type, anticipated radiosensitivity, tumor lo-cation, extent of extraspinal disease, integrity of the spinal column, and medical fitness and life expectancy of the patient. Early diagnosis and intervention are of paramount importance in improving the likelihood of functional neurologic recovery, with the maintenance of ambulation as the primary goal. Effective management of axial spinal pain involves reconstruction and stabilization of the spinal column. Although the ideal therapy has not been established, a wide range of management options is currently available.

Entities:  

Mesh:

Year:  2004        PMID: 15450875     DOI: 10.1016/j.nec.2004.04.004

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  8 in total

1.  Minimally invasive iliac screw fixation in treating painful metastatic lumbosacral deformity: a technique description and clinical results.

Authors:  Gabriel Liu; Muhammed Yaser Hasan; Hee-Kit Wong
Journal:  Eur Spine J       Date:  2016-01-19       Impact factor: 3.134

Review 2.  Metastatic spinal lesions: state-of-the-art treatment options and future trends.

Authors:  B A Georgy
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-19       Impact factor: 3.825

Review 3.  En Bloc Resection of Solitary Functional Secreting Spinal Metastasis.

Authors:  C Rory Goodwin; Michelle J Clarke; Ziya L Gokaslan; Charles Fisher; Ilya Laufer; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2015-07-16

Review 4.  Systematic Review of the Outcomes of Surgical Treatment of Prostate Metastases to the Spine.

Authors:  Michelle J Clarke; Camilo A Molina; Daryl R Fourney; Charles G Fisher; Ziya L Gokaslan; Meic H Schmidt; Laurence D Rhines; Michael G Fehlings; Ilya Laufer; Shreyaskumar R Patel; Y Raja Rampersaud; Jeremy Reynolds; Dean Chou; Chetan Bettegowda; Ehud Mendel; Michael H Weber; Daniel M Sciubba
Journal:  Global Spine J       Date:  2017-06-01

5.  CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.

Authors:  Peng Liu; Yun Liang; Libo Jiang; Houlei Wang; Shengxing Wang; Jian Dong
Journal:  Int J Oncol       Date:  2018-07-18       Impact factor: 5.650

Review 6.  Incorporating the Spine Instability Neoplastic Score into a Treatment Strategy for Spinal Metastasis: LMNOP.

Authors:  Zurab Ivanishvili; Daryl R Fourney
Journal:  Global Spine J       Date:  2014-04-28

7.  ASSESSMENT OF THE POSTERIOR APPROACH FOR SURGICAL TREATMENT OF SPINAL METASTATIC BREAST CANCER.

Authors:  Mariana Demétrio de Sousa Pontes; Breno de Paula Faleiros Pires; Felipe de Paula Albuquerque; Carlos Fernando Pereira da Silva Herrero
Journal:  Acta Ortop Bras       Date:  2020 Jan-Feb       Impact factor: 0.513

8.  Clinical outcome of surgical management for symptomatic metastatic spinal cord compression from prostate cancer.

Authors:  Yasuhide Miyoshi; Takashi Kawahara; Masahiro Yao; Hiroji Uemura
Journal:  BMC Urol       Date:  2020-09-05       Impact factor: 2.264

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.